IQInvest research note
24 SEP 2026 · 21:27 ET
LLY
Eli Lilly and Company
$1,181.89
$30.90 (+2.68%)up 2.68%
24 September 2026 · delayed 15+ min
C
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Eli Lilly and Company earns a C on excellent profit margins (>20%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and high P/E ratio (39.6) - may be overvalued. Good investment opportunity with solid fundamentals.
Adjusted for Moderate investors, Medium-term investors 6.8% suggested allocation Change these
IQ-LLY-20260924engine v1 · 7-category weighted scorecard